Protalix Biotherapeutics, Inc. (PLX)
2.48
+0.08
(+3.33%)
USD |
NYAM |
Aug 26, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Total Liabilities (Quarterly) : 38.93M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.93M |
| March 31, 2026 | 35.11M |
| December 31, 2025 | 34.12M |
| September 30, 2025 | 29.36M |
| June 30, 2025 | 28.58M |
| March 31, 2025 | 28.68M |
| December 31, 2024 | 30.21M |
| September 30, 2024 | 29.13M |
| June 30, 2024 | 62.96M |
| March 31, 2024 | 60.04M |
| December 31, 2023 | 50.86M |
| September 30, 2023 | 49.32M |
| June 30, 2023 | 49.42M |
| March 31, 2023 | 65.55M |
| December 31, 2022 | 66.43M |
| September 30, 2022 | 68.22M |
| June 30, 2022 | 70.53M |
| March 31, 2022 | 75.88M |
| December 31, 2021 | 79.70M |
| September 30, 2021 | 83.27M |
| June 30, 2021 | 104.36M |
| March 31, 2021 | 88.29M |
| December 31, 2020 | 94.97M |
| September 30, 2020 | 105.62M |
| June 30, 2020 | 106.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 113.76M |
| December 31, 2019 | 115.71M |
| September 30, 2019 | 124.58M |
| June 30, 2019 | 122.73M |
| March 31, 2019 | 120.90M |
| December 31, 2018 | 114.01M |
| September 30, 2018 | 113.69M |
| June 30, 2018 | 94.46M |
| March 31, 2018 | 104.24M |
| December 31, 2017 | 103.51M |
| September 30, 2017 | 87.13M |
| June 30, 2017 | 79.67M |
| March 31, 2017 | 140.32M |
| December 31, 2016 | 92.20M |
| September 30, 2016 | 85.58M |
| June 30, 2016 | 86.84M |
| March 31, 2016 | 84.66M |
| December 31, 2015 | |
| September 30, 2015 | 128.00M |
| June 30, 2015 | 131.09M |
| March 31, 2015 | 133.20M |
| December 31, 2014 | 134.07M |
| September 30, 2014 | 132.49M |
| June 30, 2014 | 136.44M |
| March 31, 2014 | 136.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Altimmune, Inc. | 53.00M |
| Taysha Gene Therapies, Inc. | 83.17M |
| Humacyte, Inc. | 106.83M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 110.34M |
| Shareholders Equity (Quarterly) | 71.40M |
| Debt to Equity Ratio | 0.1289 |
| Current Ratio | 2.938 |
| Net Debt Paydown Yield | -0.42% |